SPRY· Ars Pharmaceuticals Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 5 quarters
SPRY Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$868M
Enterprise value$791M
EV / EBITDA (TTM)-4.44
P/E ratio (TTM)—
Forward P/E-11.54
P/S ratio10.30
P/B ratio7.59
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$171M
Free cash flow (TTM)-$95M
Total cash$245M
Total debt$169M
Debt / equity147.49
Current ratio7.28
Income Statement
Total revenue (TTM)$84M
Revenue per share (TTM)0.85
Gross profit (TTM)$51M
EBITDA (TTM)-$178M
Net income (TTM)-$171M
EPS diluted (TTM)-1.74
Shares outstanding99,300,658
Float shares41,035,605
Profitability
Gross margin60.13%
Operating margin-147.63%
EBITDA margin-211.30%
Net margin-203.25%
Efficiency
Return on assets (TTM)-33.04%
Return on equity (TTM)-92.33%
Price History
Current price$8.74
52 Week high$18.90
52 Week low$6.66
50 day average$8.40
200 day average$10.35
Average volume (10 day)1,673,140
1-year beta0.80
1-year price target$26.20
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:41 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com